4Choi KS, Bae MK, Jeong JW, et al. Hypoxia-induced angiogenesis during carcinogenesis [ J ]. J B iochem Mol Biol, 2003,36 : 120-127.
5SHWEIKID, ITRIN A, SOFFER D, et al. Vascular endothelial growth factor induced by hypoxia may media hypoxiamediat ed angiogenesis [ J ]. Nature, 1992,359 : 843.
6MARXSEN J H, SCHMITT O, METZEN E, et al. Vascular endothelial growth factor gene expression in human breast cancer cell line MX-1 in controlled by O: availability in vitro and in vivo[J]. Ann Anat,2001,183:243.
7GiatrcmanoiakiA, KoukourakisM I, Sivrid is E, et al. Loss of expression and nuclear/cytoplasmic localization of the FOXP1 forkhead transcription factor are common events in early endometrial cancer relationship with estrogen receptors and HIF-1 alpha expression[ J]. Mod Pathol, 2006,19 ( 1 ) -9-16.
8SIVRIDIS E, GIATROMANOLAKIA, GATYER K C, et al. Association of hypoxia-inducible factors 1 aplpha and 2 aplpha with activated angiogenic pathways and prognosis in pations with endometrial carcinomal [ J ]. Cancer, 2002,95 (5) : 1055.
9Acs G, Xu X, Chu C, et al. Prognostic significance of erythropoietin expression in human endometrial carcinoma [ J]. Cancer,2004,100(11) :2376-2386.
10Fujiwaki R, Hata K, Lida K, et al. CO - expressionof vascular endothelial grow factor and thymidine phosphoryl- ase2in endometfial cancer [ J ]. Acta Obstet G ynecol Scand, 1999,78(8) :728-734.
5ZHONG H,DE-MARZO A M,LAUGHNER E,et al.Overexpression of hypoxia-inducible factor-1 alpha in common human cancers and their metastases[J].Cancer Res,1999,59:5830.
6MARXSEN J H,SCHMITT O,METZEN E,et al.Vascular endothelial growth factor gene expression in human breast cancer cell line MX-1 in controlled by O2 availability in vitro and in vivo[J].Ann Anat,2001,183:243.
7WIESENER M S,MUNCHEHAGEN D M,BERGER I,et al.Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1 alpha in clear cell renal carcinomas[J].Cancer Res,2001,61:5215.
8SIVRIDIS E,GIATROMANOLAKI A,GATTER K C,et al.Association of hypoxia-inducible factors 1 aplpha and 2 aplpha with activated angiogenic pathways and prognosis in pations with endometrial carcinoma[J].Cancer,2002,95(5):1055.
9REYNOLDS R K,HU C,BAKER U V.Transforming growth factor-alpha and insulin-like factor-1,but not epidermal growth factor,elicit autocrine stimulation of mitogenesis in endometrial cancer cell lines[J].Gynecol Oncol,1998,70:202.
10ELKAS J,GRAY K,HOWARD L,et al.The effects of tamoxifen on endometrial insulin-like growth factor-1 expression[J].Obstet Gynecol,1998,91:45.
5Han S Y,Kato H,Kato S,et al.Function evaluation of PTEN missense mutations using in viro phosphoinositide phosphatase assay[J].Cancer Res,2006,60(12):3147.
6Cerezo L,Cardenes H,Michael H.Molecular alterations in the pathogenesis of endometrial adenocarcinoma Therapeutic implications[J].Clin Trains Oncol,2006,8(4):231.
7Tamuram G J,Matsumotok,et al.Inhibition of migration,spreadind,and adhensions by tumer suppressor PTEN[J].Science,2004,280(5369):1614.
8Syrjanen A,Chang F,Syrjanen T K.Tumourigenesis associated with the p53 tumor suppressor gene[J].BrJ Cancer,1993,68(11):653.
